A look at best practices, cytomegalovirus, genetics, and cochlear implants for single-sided deafness.
What Otolaryngologists Need to Know About OTC Hearing Aids
There is reasonable concern that patients with severe hearing loss may obtain minimal benefit from OTC hearing aids and not seek a higher level of hearing rehabilitation.
Neurofibromatosis Patients See Different Benefits from CI and ABI Technology
ABI remains the standard option for surgical hearing rehabilitation in NF2, but peak performance is generally lower than that achievable with CIs.
Should Infants Who Fail their Newborn Hearing Screen Undergo Cytomegalovirus Testing?
Given the current evidence available, it is recommended that infants who fail their newborn hearing screening should undergo CMV testing.
Considerable Gaps between Self-Reported Hearing Loss and Receiving Evaluation, Treatment
Despite the high prevalence of hearing loss in the United States, researchers of a new study published in JAMA Otolaryngology–Head and Neck Surgery found substantial gaps in specialist referral patterns and the use of amplification options, including hearing aids and cochlear implants (CIs). The researchers, led by Hossein Mahboubi, MD, MPH, a resident in the […]
How Gene Editing is Changing Otolaryngology
Global Rates of Pediatric Hearing Loss Higher Than Thought
Despite advances in screening and treatment, many children are not receiving the benefits of early hearing detection and intervention
Cochlear Implants: Changing Indications and New Technology
New Research in Hearing Loss
Experts discuss hidden hearing loss and cochlear aging
Genetic Testing for Hearing Loss
- 1
- 2
- 3
- …
- 7
- Next Page »